|
Sep 21(Mon)
|
10:30-10:45
|
Conference D
|
Registration
|
Korea Drug Research Association (KDRA)
ssojuu@kdra.or.kr
|
|
|
|
|
10:45-10:55
|
|
Opening Message
|
Jae-Hyun Lee
Chair of K-BD Group
|
|
|
|
|
|
|
Session1
|
Chair: Harry Shin, CEO of NThera
|
|
|
|
|
10:55-11:10
|
|
Development of Innovative Disease-Modifying Botanical Drugs for Chronic and Refractory Diseases in the Elderly
|
Mthera Pharma Co., Ltd.
|
|
|
|
|
11:10-11:25
|
|
Development of Small-Molecule Therapeutics Targeting Post Traumatic Stress and Disorder (PTSD) via Regulation of Synaptic Plasticity
|
Psyphreno Biologics Inc.
|
|
|
|
|
11:25-11:40
|
|
Humanized Mouse Model-Based Translational Bridge Platform for Advanced Therapy Medicinal Products (ATMPs)
|
C&SR Inc.
|
|
|
|
|
11:40-11:55
|
|
AI-Powered Personalized Healthcare Solutions Based on the Microbiome
|
ImmunoBiome Inc.
|
|
|
|
|
11:55-12:10
|
|
Development of Apoptosis Enhancers for Synergistic Combination with DNA-Damaging Standard Therapies Without Additional Toxicity
|
VS Pharmtech Co., Ltd.
|
|
|
|
|
12:10-13:30
|
|
Lunch Time
|
|
|
|
|
|
|
|
Session 2
|
Chair: Soon-Woong Kim, Managing Patent Attorney of JUNGJIN IP Law Firm
|
|
|
|
|
13:30-13:45
|
|
Development of DPC and ASO therapeutics for hair loss
|
Epi Biotech Co., Ltd.
|
|
|
|
|
13:45-14:00
|
|
Discovery and Development of First-in-Class Small-Molecule Oncology Therapeutics based on Functional and Chemical Genomics
|
Checkmate Therapeutics Co., Ltd.
|
|
|
|
|
14:00-14:15
|
|
Development of novel anti-atherosclerotic drugs targeting vascular senescence and Development of multi-targeting anti-Alzheimer‘s drugs
|
AgingTarget Inc.
|
|
|
|
|
14:15-14:30
|
|
Development of an Anti-Canine PD-L1 antibody for Companion Animals
|
NodCure Inc.
|
|
|
|
|
14:30-14:45
|
|
Imaging-Based Dosimetry-Driven Precision Radiopharmaceutical Therapy Platform
|
RayMed Co., Ltd.
|
|
|
|
|
14:45-15:00
|
|
Break Time
|
|
|
|
|
|
|
|
Session 3
|
Chair: Dong-Hyun Lee, Division Director of RMAF
|
|
|
|
|
15:00-15:15
|
|
Global Commercialization of Precision Medicine Platform Technology for Atopic Dermatitis
|
CUePEAK BIO
|
|
|
|
|
15:15-15:30
|
|
Development of Oral Alzheimer's Disease Therapeutics and Innovative Drugs through
|
NeuroBBi
|
|
|
|
|
15:30-15:45
|
|
Development of an EpCAM-Targeted Oncolytic Virus Therapy for Solid Tumors with Peritoneal Metastases Using an HSV-Based Targeting Platform
|
Gencellmed Inc.
|
|
|
|
|
15:45-16:00
|
|
Development of a whole genome sequencing (WGS)-based Human Digital Twin AI platform
|
Predictive AGI
|
|
|
|
|
16:00-16:15
|
|
Development of cell and gene-based cancer immunotherapies (NK cell, CAR-T/CAR-MILs) and companion animal biopharmaceuticals
|
VaxCell-Bio
|
|
|
|
|
16:15
|
|
Closing
|
|
|
|
KYUNGYON EXHIBITION CORP.
